Company news

Vivani Medical, Inc. news in 2026

Vivani Medical, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Vivani Medical Announces Private Placement Equity Financing

November 16, 2026

Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects

November 12, 2026

Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update

November 11, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences

October 12, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences

September 3, 2026

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

August 6, 2026

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

July 14, 2026

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

July 7, 2026

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

July 1, 2026

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

June 26, 2026

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

June 25, 2026

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

June 22, 2026

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

May 28, 2026

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 25, 2026

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

January 29, 2026

Vivani Medical, Inc. Announces Closing of Common Stock Offering

January 27, 2026

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

January 25, 2026

Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026

January 22, 2026

Decks in 2026